Back

Regulation of B cell tolerance and autoimmunity by miR-130b

Herrero-Fernandez, B.; Gonzalez-Molina, M. d. P.; Gamez-Reche, L.; Prieto-Munoz, A. M.; Sanz, J.; Gonzalo, T.; Moreno, A.; Nemazee, D.; Xiao, C.; Manas, L.; Gonzalez-Martin, A.

2025-01-24 immunology
10.1101/2025.01.22.634242 bioRxiv
Show abstract

Breakdown of B cell tolerance is a central feature of autoimmune diseases, yet the molecular mechanisms underlying the female predominance of these diseases remain unclear. Here, we identified miR-130b as an essential component of a miRNA network, defined by the GUGCA seed motif, that regulates central B cell tolerance. Elevated miR-130b levels impaired tolerance by promoting the survival of immature B cells upon B cell antigen receptor engagement. This network converged on the estrogen receptor pathway through downregulation of Esr1 and Pten. Genetic ablation of Esr1 in immature B cells was sufficient to compromise central B cell tolerance in females, but not in males, revealing an unrecognized role for ER in this process. In males, Esr1 deficiency reduced bone marrow B cell numbers, whereas in females, B cell numbers were preserved, with a greater proportion of cells displaying lower surface CD19 levels. Transcriptomic analysis revealed sex-specific genetic programs characterized by defective B cell development and skewed immunoglobulin gene usage in males, and increased PI3K-AKT signaling in females. In females, this molecular rewiring compensated for developmental defects, but also attenuated central tolerance mechanisms, allowing the escape of autoreactive B cells to the periphery. In patients with multiple sclerosis, elevated levels of miR-130b in circulating vesicles correlated with more severe disease, including increased formation of new demyelinating lesions, cognitive decline, and neurodegeneration. Together, our findings identify a sex-specific ER-dependent checkpoint in B cell tolerance controlled by a seed-driven miRNA network, providing a mechanistic framework for female predisposition to autoimmunity.

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

1
Immunity
58 papers in training set
Top 0.1%
33.7%
2
Nature Communications
4913 papers in training set
Top 13%
12.6%
3
Cell Reports
1338 papers in training set
Top 7%
6.5%
50% of probability mass above
4
Science Immunology
81 papers in training set
Top 0.3%
5.0%
5
Nature Immunology
71 papers in training set
Top 0.3%
5.0%
6
Journal of Experimental Medicine
106 papers in training set
Top 0.6%
4.4%
7
eLife
5422 papers in training set
Top 32%
2.7%
8
Science
429 papers in training set
Top 11%
2.4%
9
Cell
370 papers in training set
Top 10%
1.9%
10
Science Translational Medicine
111 papers in training set
Top 2%
1.8%
11
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 30%
1.8%
12
Journal of Clinical Investigation
164 papers in training set
Top 3%
1.7%
13
PLOS Biology
408 papers in training set
Top 13%
1.3%
14
EMBO reports
136 papers in training set
Top 5%
1.0%
15
Cellular & Molecular Immunology
14 papers in training set
Top 2%
0.8%
16
Science Advances
1098 papers in training set
Top 27%
0.8%
17
Cell Host & Microbe
113 papers in training set
Top 5%
0.8%
18
Acta Neuropathologica
51 papers in training set
Top 1%
0.8%
19
EMBO Molecular Medicine
85 papers in training set
Top 5%
0.7%
20
Molecular Cell
308 papers in training set
Top 10%
0.7%
21
JCI Insight
241 papers in training set
Top 9%
0.5%
22
Cell Metabolism
49 papers in training set
Top 3%
0.5%
23
Diabetes
53 papers in training set
Top 0.8%
0.5%